Administration of pegfilgrastim from the first cycle of chemotherapy reduces febrile neutropenia in elderly patients with solid tumours

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1053, 2005-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pegfilgrastim superior to filgrastim for preventing febrile neutropenia

By  

Inpharma, Vol. 1, Iss. 1606, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Pegfilgrastim fits the bill for febrile neutropenia prophylaxis in Europe

By  

Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Pegfilgrastim fits the bill for febrile neutropenia prophylaxis in Europe

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 517, 2006-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Irinotecan: Febrile neutropenia in elderly patients: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1372, 2011-01 ,pp. : 21-22

Adis International

Access to resources Recommend Favorite

Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia

By Rofail Pierre   Tadros Mariam   Ywakim Riham   Tadrous Mina   Krug Allison   Cosler Leon E  

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 12, Iss. 6, 2012-12 ,pp. : 699-709

Informa Healthcare

Access to resources Recommend Favorite